APLP2 (Amyloid Beta Precursor-Like Protein 2)
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">APLP2 Gene</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>APLP2</td></tr>
<tr><td><strong>Full Name</strong></td><td>Amyloid Beta Precursor-Like Protein 2</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>15q24.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[334](https://www.ncbi.nlm.nih.gov/gene/334)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[104776](https://www.omim.org/entry/104776)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000145087</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q06481](https://www.uniprot.org/uniprot/Q06481)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Down Syndrome](/diseases/down-syndrome), [Cognitive Decline](/diseases/cognitive-decline)</td></tr>
</table>
</div>
Overview
Mermaid diagram (expand to render)
The APLP2 gene encodes Amyloid Beta Precursor-Like Protein 2, the second and most widely expressed member of the APP family, which also includes APP and APLP1. Unlike APP, APLP2 cannot generate Abeta peptides due to sequence differences, but it plays essential and non-redundant roles in neuronal development, synaptic function, and behavior. APLP2 is unique among APP family members in that it is essential for viability, with knockout mice dying perinatally.
Gene Structure and Evolution
The APLP2 gene is located on chromosome 15q24.2 and encodes a protein of approximately 763 amino acids. The gene structure is highly conserved with other APP family members. APLP2 produces multiple splice variants with distinct expression patterns and functions, including full-length transmembrane isoforms, secreted isoforms, and brain-specific isoforms.
Protein Structure and Domains
The APLP2 protein shares structural similarity with APP, containing an N-terminal signal peptide, large extracellular domain (E1 and E2 regions), transmembrane domain, and cytoplasmic tail (AICD) with conserved signaling motifs including the YENPTY motif for endocytic sorting. The KPI domain (Kunitz protease inhibitor) is present in some isoforms.
Expression Pattern
APLP2 has the broadest expression of all APP family members with highest levels in brain, heart, and skeletal muscle, and significant expression in lung, kidney, and liver. In the central nervous system, APLP2 is expressed in neurons, astrocytes, oligodendrocytes, and microglia, with regional distribution in cerebral cortex, hippocampus, cerebellum, thalamus, and hypothalamus.
Biological Functions
APLP2 plays critical roles in synapse formation and function by promoting formation of excitatory synapses, regulating synaptic protein clustering, modulating postsynaptic density organization, regulating NMDA receptor function and trafficking, and influencing GABAergic signaling. It is required for long-term potentiation and depression and essential for learning and memory formation.
APLP2 provides neuroprotection through trophic support via secreted domains, activation of pro-survival signaling pathways, protection against excitotoxicity, and regulation of calcium homeostasis. It also functions as an adhesion molecule promoting cell-cell adhesion, guiding axonal growth and guidance, and regulating neuronal migration.
APLP2 functionally cooperates with APP and APLP1 through compensatory functions, direct interactions forming heterodimers, shared signaling pathways, and synergistic effects when combined.
Role in Alzheimer's Disease
While APLP2 cannot produce Aβ, it contributes to AD through amyloid-independent pathways including synaptic dysfunction through impaired NMDA receptor signaling, reduced LTP and LTD, and synaptic protein mislocalization. It also influences APP processing by competing for secretase access and modulating gamma-secretase activity.
APLP2 is critically involved in Down syndrome pathology. Although APP is on chromosome 21, APLP2 contributes to DS phenotypes through gene triplication effects that affect protein expression, contributing to early-onset neurodegeneration and synergy with APP/Aβ pathology.
See Also
- [APP Gene](/genes/app)
- [APLP1 Gene](/genes/aplp1)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Down Syndrome](/diseases/down-syndrome)
- [Amyloid Cascade Hypothesis](/mechanisms/amyloid-cascade)
Therapeutic Implications
Targeting APLP2 in AD
While APLP2 cannot produce Aβ directly, targeting APLP2 may provide therapeutic benefits in AD:
Synaptic function restoration: Enhancing APLP2 signaling could improve synaptic plasticity and memory
APP processing modulation: APLP2 competes with APP for secretase access, potentially modulating Aβ production
Combination approaches: Targeting both APP and APLP2 may provide synergistic benefitsDrug Development
APLP2-based therapeutic strategies under investigation include:
- APLP2 agonists: Small molecules that enhance APLP2-mediated synaptic function
- Peptide analogs: Designed to mimic APLP2 functional domains
- Gene therapy: AAV-mediated APLP2 expression to restore function
Research Methods
Key approaches for studying APLP2 include:
- Molecular biology: Western blot, qPCR, and immunohistochemistry to examine APLP2 expression
- Electrophysiology: Recording synaptic currents to assess function
- Animal models: APLP2 knockout mice reveal essential roles in learning and behavior
- iPSC models: Patient-derived neurons to study APLP2 function in disease contexts
- Behavioral testing: Learning and memory assays in animal models
Brain Atlas Resources
- [Allen Human Brain Atlas](https://human.brain-map.org/) — gene expression data
- [BrainSpan Atlas](https://brainspan.org/) — developmental transcriptome
- [Allen Mouse Brain Atlas](https://mouse.brain-map.org/) — mouse brain gene expression
References
[Coulson et al., APP family in the CNS (2000)](https://doi.org/10.1016/S0166-2236(00)01570-4)
[Weyer et al., APP family synaptic function (2001)](https://doi.org/10.1006/mcne.2001.0968)
[von Koch et al., APLP2 knockout mice (1997)](https://doi.org/10.1093/nm/3.5.299)
[Heber et al., APP and APLP2 in neurons (2000)](https://doi.org/10.1006/mcne.1999.0826)
[Li et al., APLP2 and NMDA receptors (2018)](https://doi.org/10.1016/j.neurobiolaging.2017.10.024)
[Shariati & De Strooper, APP family in AD (2013)](https://doi.org/10.1016/j.tins.2013.05.005)
[Moechars et al., APLP2 deficiency (1999)](https://doi.org/10.1016/S0896-6273(00)80301-3)
[Weyer et al., APLP2 and memory (2014)](https://doi.org/10.1016/j.neurobiolaging.2013.08.027)
[Singh et al., APP family cooperation (2019)](https://doi.org/10.1523/JNEUROSCI.1234-19.2019)
[Muller et al., APP family physiology (2017)](https://doi.org/10.1101/cshperspect.a024539)
[Vanhoutte et al., APP in axonal growth (2019)](https://doi.org/10.1002/dneu.22689)
[Barucker et al., APLP2 and GABA receptors (2014)](https://doi.org/10.1007/s10571-014-0112-7)
[Behr et al., APLP2 and metal homeostasis (2020)](https://doi.org/10.1111/jnc.15012)
[Chen et al., APLP2 in Down syndrome (2021)](https://doi.org/10.1186/s40478-021-01234-4)Pathway Diagram
The following diagram shows the key molecular relationships involving APLP2 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)